canrenoic acid has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackman, D; Bulluck, H; Davies, J; Fröhlich, GM; Gamma, R; Garg, P; Greenwood, JP; Hausenloy, DJ; Mathur, A; Mohdnazri, S; Moon, JC; Nicholas, JM; Sirker, A | 1 |
| Drogies, T; Felix, SB; Ghaleh, B; Krieg, T; Schmidt, K; Tissier, R | 1 |
1 trial(s) available for canrenoic acid and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
Topics: Aged; Canrenoic Acid; Cardiac Imaging Techniques; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Pilot Projects; Proof of Concept Study; Spironolactone; ST Elevation Myocardial Infarction; Ventricular Remodeling | 2019 |
1 other study(ies) available for canrenoic acid and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion.
Topics: Animals; Canrenoic Acid; Eplerenone; Ischemic Preconditioning, Myocardial; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Phosphotransferases; Rabbits; Rats; Rats, Wistar; Spironolactone | 2010 |